Search research articles
Contact Us
Filters
Showing results (181-190 of 213) with videos related to
Page
of 22
Sort By:
European Journal of Heart Failure
|
October 5, 2020
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium
William T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 18, 2024
American Heart Association Cardiogenic Shock Registry: Design and Implementation
David A Morrow, Mariell Jessup, William T Abraham, et al.
American Heart Journal
|
November 1, 2020
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics
Glenn M Chertow, Pablo E Pergola, Rajiv Agarwal, et al.
European Journal of Heart Failure
|
February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
Clara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
American Heart Journal
|
May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and design
Gervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
Circulation. Heart Failure
|
March 21, 2025
Multiregional Implementation Initiative's Impact on Guideline-Based Performance Measures for Patients Hospitalized With Heart Failure: IMPLEMENT-HF
Andrew J Sauer, Chandler Beon, Sruthi Cherkur, et al.
European Journal of Heart Failure
|
October 30, 2024
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial
Yogesh N V Reddy, Javed Butler, Kevin J Anstrom, et al.
JACC. Heart Failure
|
November 17, 2020
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium
William T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
The New England Journal of Medicine
|
April 11, 2014
Spironolactone for heart failure with preserved ejection fraction
Bertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
JAMA
|
July 27, 2021
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial
Adam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 213) with videos related to
Sort By:
Page
of 22
European Journal of Heart Failure
|
October 5, 2020
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium
William T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 18, 2024
American Heart Association Cardiogenic Shock Registry: Design and Implementation
David A Morrow, Mariell Jessup, William T Abraham, et al.
American Heart Journal
|
November 1, 2020
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics
Glenn M Chertow, Pablo E Pergola, Rajiv Agarwal, et al.
European Journal of Heart Failure
|
February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
Clara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
American Heart Journal
|
May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and design
Gervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
Circulation. Heart Failure
|
March 21, 2025
Multiregional Implementation Initiative's Impact on Guideline-Based Performance Measures for Patients Hospitalized With Heart Failure: IMPLEMENT-HF
Andrew J Sauer, Chandler Beon, Sruthi Cherkur, et al.
European Journal of Heart Failure
|
October 30, 2024
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial
Yogesh N V Reddy, Javed Butler, Kevin J Anstrom, et al.
JACC. Heart Failure
|
November 17, 2020
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium
William T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
The New England Journal of Medicine
|
April 11, 2014
Spironolactone for heart failure with preserved ejection fraction
Bertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
JAMA
|
July 27, 2021
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial
Adam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
Page
of 22